- Home
- / Aether Biomedical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Aether Biomedical financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
ZŁ4.7 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| PLN | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|
| Revenue | 1.0M | 911.4K | 4.7M |
| Cost of goods sold | 918.7K | 3.4M | 5.8M |
| Gross profit | 107.1K | (2.5M) | (1.1M) |
| Gross profit margin, % | 10.4% | -277.5% | -23.4% |
| General and administrative expense | 567.4K | 1.3M | 1.7M |
| Operating expense total | 3.2M | 2.6M | 3.0M |
| Depreciation and amortization | 163.3K | 195.1K | 699.8K |
| EBIT | (3.7M) | ||
| EBIT margin, % | -77.9% | ||
| Interest expense | 158.8 | 220.8K | |
| Pre tax profit | (4.4M) | (4.6M) | |
| Net Income | (1.8M) | (4.4M) | (4.6M) |